Bottom line
Is SLIYX a good fund? The bottom line
SLIYX is the Class Y share class of Simt Multi-asset Income Fund, an actively managed allocation / balanced mutual fund from SEI.
Annual fees run 0.96% — about $96 a year on every $10,000 invested, more expensive than 55% of allocation / balanced funds we track.
It returned +10.2% over one year, +3.6% a year over five years, +5.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $504 million in net assets and 954 holdings, its largest position is United States of America (4.3%) and the top 10 make up 11.3% of the portfolio.
What stands out
- Broadly diversified (954 holdings)
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What SLIYX invests in
The Fund seeks total return with an emphasis on current income.
"Under normal circumstances, the Fund will seek to generate total return with an emphasis on income by selecting investments from among a broad range of asset classes based upon SEI Investments Management Corporation's (SIMC) or the sub-adviser's (each, a Sub-Adviser and collectively, the Sub-Advisers) expectations for income and, to a lesser extent, capital appreciation. The asset classes used and the Fund's allocations among asset classes will be determined based on SIMC's or the Sub-Adviser's views of fundamental, technical or valuation measures. The Fund's allocations among asset classes may be adjusted over short periods of time. At any point in time, the Fund may be diversified across many asset classes or concentrated in a limited number of asset classes. The Fund may obtain its exposures to the asset classes by investing directly in securities and other investments or…
From the fund's prospectus (filed Jan 28, 2026).
SLIYX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SLIYX | +10.2% | +3.6% | +5.1% |
| Allocation / Balanced median | +11.0% | +5.7% | +6.7% |
Source: Fund prospectus, as of Dec 31, 2025
What SLIYX costs
On a $10,000 investment, SLIYX's 0.96% expense ratio costs about $96 a year. The prospectus estimates $1,178 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.
SLIYX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | United States of America | 4.31% |
| 2 | Morgan Stanley & Co, Inc | 2.00% |
| 3 | United States of America | 1.16% |
| 4 | United States of America | 0.79% |
| 5 | Johnson & Johnson | 0.57% |
| 6 | Altria Group, Inc. | 0.54% |
| 7 | Dbs Group Holdings Ltd | 0.51% |
| 8 | Novartis AG | 0.48% |
| 9 | Abbvie Inc. | 0.47% |
| 10 | Merck & Co., Inc. | 0.47% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 11.3% of the fund. See all top 25 holdings and asset mix →